SCHEMBL2616124

SCHEMBL2616124

C1=CC2=C(C1)CCCN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13775942 0.93 FKBP5 (0.34)
SCHEMBL8204032 0.85
SCHEMBL8346675 0.80 OR51E2 (0.31)
SCHEMBL21899203 0.79 FKBP5 (0.31)
SCHEMBL1000742 0.74 FKBP5 (0.33)
SCHEMBL4565785 0.74
Hydrochloric Acid SCHEMBL4401074 0.72
SCHEMBL3518015 0.71 OR51E2 (0.37)
SCHEMBL28888013 0.68
SCHEMBL2505718 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3847159-A2 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE Magenta Therapeutics, Inc. (US) 2021-07-14 EP claimed
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2023-05-04 US disclosed
US-20230128889-A1 REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS Université Libre de Bruxelles (BE) 2023-04-27 US disclosed
US-8202858-B2 Vasopressin V1a antagonists VANTIA LIMITED (GB) 2012-06-19 US disclosed
US-20120101082-A1 VASOPRESSIN V1A ANTAGONISTS BATT ANDRZEJ ROMAN (GB) 2012-04-26 US disclosed
US-20090029965-A1 Vasopressin V1a Antagonists FERRING B.V. (NL) 2009-01-29 US disclosed
US-20080275026-A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists FERRING B.V. 2008-11-06 US disclosed
US-7407949-B2 Benzamide derivatives as oxytocin agonists and vasopressin antagonists FERRING B.V. (NL) 2008-08-05 US disclosed